Karen Leroy

12PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 11, 2026
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.

|Feb 06, 2026
Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Medina Kalimulaeva, Leen Van Langenhoven, Karen Leroy

|Aug 26, 2025
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.

Florence Joly, Alexandra Leary, Isabelle Ray-Coquard

|Dec 04, 2024
Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.

Léa Paolini, Thi Tran, Stéphanie Corgnac

|Nov 07, 2024
Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma.

Jeremy Slomka, Hugo Berthou, Audrey Mansuet-Lupo

|Oct 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Gary Birsen, Valérie Gounant, Nicolas Girard

Pageof 2

Frequent Collaborators

5 joint publications

Marie Wislez

3 joint publications

Elizabeth Fabre

3 joint publications

Etienne Giroux-Leprieur

3 joint publications

Gary Birsen